dorsaVi Ltd (DVL.AX)

0.0110 0.0000 (0.00%) At close: 10:40AM AEST

dorsaVi Ltd

350 Collins Street
Suite 1 Level 6
Melbourne, VIC 3000
Australia
61 3 8360 3321
https://www.dorsavi.com

Sector(s): Technology
Industry: Scientific & Technical Instruments
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Andrew James Ronchi B.App.Sci., GAICD, Ph.D.	Co-Founder, MD, CEO & Executive Director	210.9k	N/A	N/A
Mr. Aaron Chan	Chief Financial Officer	N/A	N/A	N/A
Ms. Mary Stewart	Account Manager & Head of Clinical Sales	N/A	N/A	N/A
Mr. Daniel Mathew Ronchi Ass.Deg.Law	Chief Technology Officer	139.48k	N/A	N/A
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

dorsaVi Ltd engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States. It operates through two segments: Clinical and Workplace. The company provides ViMove+, a clinical and sports solutions; ViSafe, a wearable sensor technology that analyzes how workforce moves and reviews and pinpoints unsafe work practices that leads to workplace injury; and myViSafe technology for organizations and on-site clinicians to identify and mitigate injury risk in the workplace and drive behavioral changes. It also offers ViPerform, a wearable and wireless movement sensor technology that offers objective data to assess risk of sport injury and guides athletic training and recovery programs; telehealth solutions; and professional suites. It serves clinic and sports, workplace, and research industries. dorsaVi Ltd was incorporated in 2008 and is based in Melbourne, Australia.

Corporate governance

dorsaVi Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.